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Simplantation and 8 weeks afterward, the concentrations of the 3 antimicrobials were
measured by high-performance liquid chromatography (HPLC).
Results: The 2 pigs that received unbonded grafts plus bacteria had to be
sacriﬁced during the ﬁrst 2 postoperative weeks because of severe infection and
septicemia; both pigs had high bacterial counts (6.25106 and 1.38107 CFU/graft).
S. aureus–treated bonded grafts showed no bacterial growth on explantation. The
control (unbonded and untreated) graft showed bacterial growth (1.8103 and
7.27103 CFU/graft) that presumably reﬂected direct accidental perioperative
bacterial contamination; S. cohnii ssp urealyticus, but not S. aureus, was isolated.
The histopathologic and clinical data conﬁrmed the microbiologic ﬁndings. Only
one pig that received a bonded graft showed histopathologic evidence of a healed
perigraft abscess. Analysis of antimicrobial concentrations showed that the initial
dosage was sufﬁcient to prevent any bacterial infection during the 8-week post-
operative period.
Conclusions: Our results suggest that bonding aortic grafts with this combina-
tion of 3 antimicrobials prevented perioperative aortic graft infection for at least
8 weeks in an animal model. The concentration of these chemicals was
sufﬁcient to prevent or eradicate any infections. Further studies are needed to explore
the ability of this novel graft to combat one of the most feared complications in
vascular surgery.
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Background: The success rate of endovascular therapy (EVT) for long chronic total
occlusion (CTO) of femoropopliteal arteries has improved because of devices
development and the introduction of the echo or IVUS guided EVT. But now this is
still challenging. In the diagnosis of peripheral artery disease, duplex ultrasonography
is noninvasive, simple and usefulness, but it was impossible to assess the lesion
morphology. Elastography is an ultrasonographic method that has been examined as
a diagnostic tool for breast lesions. We applied this method to hardness measurement
of CTO lesions by our original method. Our aim was to investigate the usefulness of
the ultrasonography (US) "vascular elastography (VE)" in EVT for long CTO lesions
of SFA.
Methods: In 1274 consecutive cases which underwent EVT between April 2010 and
May 2013, we focused on 57 cases of EVT for long CTO of femoropopliteal
arteries, which CTO length was more than 150mm. We assessed the CTO lesions by
duplex US and "VE" about lesion hardness with our original methods before
procedure. US was performed with 8 MHz linear transducer (Aprio XG/500,
TOSHIBA, Japan), and off-line analysis of "VE" was performed with elasto-Q
(TOSHIBA, Japan). We originally categorized into ﬁve types by original VE score.
The ratio of hard appearance portion (VE score 0-1) to CTO (H/T ratio) was evaluated.
Comparing investigation about procedure results was performed between hard group
(H group: hard portion>20%) and non-hard group (NH group: hard portion<20%). In
EVT, guide wire was penetrated with US guided from body surface without
ﬂuoroscopy.
Results: We could assess elastogram of target CTO lesions in all cases (H group: 27
cases, S group: 30 cases). No signiﬁcant difference was detected in CTO lesion
length (H: 28.96.8mm, S: 26.64.7mm). Hard portions were detected in CTO
lesions (H: 10.26.9mm, H/T ratio 32.515.8% vs. S: 1.81.8mm, H/T ratio
7.36.6%; p<0.001). Operation time in H group was longer than S group
(H: 248.0115.1min vs. S: 142.942.1min; p¼0.01). Success rate was H: 92.6% vs.
S: 100%. No signiﬁcant difference was detected in case of retrograde approach
from popliteal artery (H: 29.6%, S: 10.0%). Retrograde approach was needed in only
17 cases which distal site of CTO was VE score 0 to 2 (VE score 0-2: 29.8% vs. 3-4:
0%; p<0.01).Cases in S group could be penetrated with hydrocoat soft guidewire
(12.1% vs. 65.2%; p<0.001). In 11 cases, CTO site was all soft appearance as VE
score 3 to 4. A hydrophilic soft guide wire could pass the lesion easily. Therefore we
successfully performed thrombectomy and distal protection preventing for distal
embolism.
Conclusions: "Vascular Elastography" might be able to predict the difﬁculty of EVT,
useful when we decide strategies and selections of device because we could assess the
vascular morphology noninvasively before procedure. VE could detect the hard pla-
que which difﬁcultly penetrated without calciﬁcation.B166 JACC Vol 62/18/Suppl B j October 27–NTCT-552
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Background: In endovascular therapy (EVT) for superﬁcial femoral artery
(SFA), nitinol selfexpanding stent has been useful compared to only balloon
angioplasty. However strategy for in-stent restenosis (ISR) after SFA stenting was
unclear. Nitinol selfexpanding drug-eluting stent (DES) for SFA has approved in our
country. The primary patency of DES was higher than bare-metal stent (BMS). Our
aim was to investigate clinical outcomes after endovascular therapy (EVT) for BMS-
ISR in SFA.
Methods: In 710 consecutive cases which underwent EVT for SFA between April
2007 and August 2012, we analyzed 68 consecutive cases (74 limbs) which underwent
secondary EVT for SFA lesions of BMS-ISR. In secondary EVT, strategy was only
balloon angioplasty (A group: 24 limbs, 37.5%), nitinol selfexpanding bare metal
stenting (BMS group: 26 limbs, 40.6%) or nitinol selfexpanding pclitaxel-eluting
stenting (Zilver PTX) (DES group: 24 limbs, 21.9%). Either angiography (diameter
stenosis>50%) or duplex ultrasoundgraphy (peak systolic velocity ratio >2.5) were
used at six months follow up to deﬁne restenosis.
Results: Mean age of patient was 67.69.6 years old; diabetic patient was 35 cases
(51.5%). 21 limbs (28.4%) were over Rutherford category 4. In primary EVT,
S.M.A.R.T Control stent or Zilver stent were deployed (mean diameter: 6.60.7mm,
total length 135.893.8mm). In secondary EVT, cases of focal stenosis were 16 limbs
(21.6%), diffuse stenosis were 34 limbs (46.0%), stent fracture were 3 limbs (4.1%)
and 24 limbs (32.4%) were total occluded with thrombus. After secondary EVT,
restenosis rate in DES group was the lowest (DES group: 0 limb vs. A group: 6 limbs,
25.0% vs. BMS group: 5limbs, 19.2%; p<0.01).
Conclusions: In EVT for in-stent restenosis of SFA, nitinol selfexpanding paclitaxel-
eluting stenting might be useful.
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Background: The "Tack-It", a novel metallic 6mm spot-scaffolding technology
was designed to seal local vascular dissections and decrease the risk of vascular
injury. This is achieved through a lower outward radial force and reduction in the
material surface in contact with the vessel compared to the current standard peripheral
stents.
Methods: Superﬁcial femoral arteries of 10 Yucatan swine were randomized to the
implantation of either self-expanding Tacks (n¼4 tacks 6mm each per 40mm segment;
10 arteries) or a self-expanding nitinol stent (40mm Cordis SMART stent; n¼10).
Following implantation, both groups were post-dilated at a 1.1:1.0 balloon to artery
ratio. After 28 days, the target arterial segments were harvested for histological
analysis.
Results: At baseline, angiography demonstrated similar reference vessel diameter
(Tack, 3.810.18mm vs. stent, 4.010.32mm, p¼NS). At 28 days, the minimal
lumen diameter analysis indicated a higher neointimal proliferation in the stent group
(2.600.91mm) compared to the Tack (3.450.28mm) leading to a higher percent
diameter of stenosis (stent 41.517.7% vs. Tack 15.03.2%, p<0.05). The histo-
logical analysis supported the angiographic data. The injury score demonstrated
a higher level of injury caused by the stent deployment (0.440.24) compared to the
Tack (0.120.07, p<0.0001) producing less neointimal proliferation (Neointimal
thickness; stent 0.590.26mm vs. Tack .0.140.034mm; p<0.0001).
Conclusions: In femoral arteries of normal Yucatan swine, this novel peripheral
vascular spot-scaffolding technology maintains lumen patency in the targeted segment
length with less foreign material and lower vascular injury and neointimal prolifera-
tion when compared to standard self-expanding nitinol stents.ovember 1, 2013 j TCT Abstracts/POSTER/Endovascular Intervention
